Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Edgewise Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 179 | 1 | 173 | −5 |
| Shares | 118.7M | 47.8K | 112.0M | −6.73M (−5.7%) |
| Value | $1.56B | $626.1K | $1.82B | +$259.7M (+16.7%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 75,276 | $1.22M | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 57,300 | $929.4K | 0.02% |
| HRT Financial LP | 52,203 | $846.0K | 0.00% |
| Optimize Financial Inc | 27,283 | $442.5K | 0.23% |
| Two Sigma Investments, LP | 26,266 | $426.0K | 0.00% |
| Trexquant Investment LP | 22,625 | $367.0K | 0.00% |
| Fox Run Management, L.L.C. | 20,471 | $332.0K | 0.05% |
| Envestnet Asset Management Inc | 10,837 | $175.8K | 0.00% |
| SG Americas Securities, LLC | 9,881 | $160.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 2,304 | $37.4K | 0.00% |
| Kayne Anderson Rudnick Investment Management LLC | 622 | $10.1K | 0.00% |
| Optiver Holding B.V. | 468 | $7.59K | 0.00% |
| Advisory Services Network, LLC | 151 | $2.46K | 0.00% |
| Larson Financial Group LLC | 135 | $2.19K | 0.00% |
| Allworth Financial LP | 33 | $536 | 0.00% |
| Montag A & Associates Inc | 16 | $260 | 0.00% |
| Clearstead Advisors, LLC | 4 | $65 | 0.00% |
Sold out (22)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Polar Capital Holdings Plc | 975,000 | $12.8M |
| Foresite Capital Management VI LLC | 585,000 | $7.67M |
| Voloridge Investment Management, LLC | 284,551 | $3.73M |
| Walleye Capital LLC | 86,882 | $1.14M |
| Twinbeech Capital LP | 78,280 | $1.03M |
| Soleus Capital Management, L.P. | 76,493 | $1.00M |
| XTX Topco Ltd | 60,739 | $796.3K |
| UBS Oconnor LLC | 55,292 | $724.9K |
| Verition Fund Management LLC | 44,069 | $577.7K |
| Tudor Investment Corp Et Al | 41,663 | $546.2K |
| Quantbot Technologies LP | 41,463 | $543.6K |
| Skandinaviska Enskilda Banken AB (publ) | 37,591 | $492.8K |
| Engineers Gate Manager LP | 34,909 | $457.7K |
| Aquatic Capital Management LLC | 27,042 | $354.5K |
| Numerai GP LLC | 22,353 | $293.0K |
| Brevan Howard Capital Management LP | 13,561 | $177.8K |
| Nebula Research & Development LLC | 13,219 | $173.3K |
| HSBC Holdings PLC | 10,712 | $142.3K |
| STRS Ohio | 6,100 | $80.0K |
| Skopos Labs, Inc. | 1,314 | $17.2K |
| Quarry LP | 311 | $4.08K |
| Riggs Asset Managment Co. Inc. | 49 | $643 |
Not filed for Q3 2025 yet (1)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 47,755 | $626.1K |